We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » India Mulls Risk-Based Pre-Inspections to Address Substandard Drugs
India Mulls Risk-Based Pre-Inspections to Address Substandard Drugs
India’s Ministry of Health is proposing that drug regulators and drugmakers implement several measures to improve the quality of drugs in the country’s supply chain, following a government estimate that 10 percent of them are substandard.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor